[177Lu]Lu-PKB3 demonstrated 1.5-fold higher activity uptake in the tumor and pancreas (a GRPR-expressing organ (Varasteh et al. 2015)) compared to [177Lu]Lu-PKB2. Here, GRPR is linked to neoplasm.